A landmark 2026 study in Nature Aging reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as a natural brake on the cGAS-STING inflammatory pathway. As PEP levels decline with age, chronic inflammaging accelerates — and restoring PEP in animal models delays aging phenotypes and improves cognition.
A landmark Science study reveals that genes control over 50 percent of lifespan variation. Meanwhile, the PROACT trial uses polygenic risk scores to find hidden heart disease, and whole genome sequencing is entering routine clinical care. Precision medicine in 2026 is no longer a promise. It is arriving.
A closer look at Yamanaka factors, partial reprogramming, David Sinclair, Altos Labs, and the widening gap between real age-reversal science and the hype surrounding it.
First-generation senolytics like dasatinib plus quercetin showed only subtle effects in human trials. A new generation of senolytic CAR-T cells borrows cancer immunotherapy and retrains it to hunt senescent cells. Here is what the 2026 research reveals about the next frontier of cellular longevity medicine.
A cluster of landmark studies is forcing scientists to ask a radical question: could the drugs that conquered obesity also slow the biological clock? The answer is more complicated, and more important, than the headlines suggest. For most of their clinical history, GLP-1 receptor agonists were diabetes drugs. Then they became weight loss blockbusters. Now,…
A landmark 2021 Stanford study found that a diet rich in fermented foods increased gut microbiome diversity and lowered 19 inflammatory proteins, while a high fiber diet did not. Here is what the science shows, how it connects to the four fundamentals of nutrition, breath, sleep, and movement, and what you can do starting with your next meal.
Roughly one in five adults worldwide carries a genetic condition that roughly doubles their lifetime cardiovascular risk. Lipoprotein(a) is invisible to standard cholesterol panels, cannot be lowered by diet or statins, and affects an estimated 1.4 billion people. In 2026, the first cardiovascular outcomes trial of a drug designed to lower Lp(a) directly is expected to read out, potentially reshaping preventive cardiology.
Scientists at MUSC, using NASA-developed MRI technology, have identified a previously unknown lymphatic drainage hub in the human brain: the middle meningeal artery. The discovery reshapes our understanding of how the brain clears Alzheimer’s-linked proteins and why sleep, exercise, and metabolic health protect cognitive longevity.
Grip strength outperforms blood pressure as a mortality predictor. A 2022 BMJ meta-analysis found that 30 to 60 minutes of resistance training per week cuts all-cause mortality by 15 percent. Here is what the new science of muscle, myokines, and sarcopenia reveals about why strength training may be the most important longevity intervention most adults are still skipping, and the minimum effective dose to start this week.
More than 173 AI-discovered drug programs are now in clinical development, with the first Phase III readouts arriving this year. From Insilico Medicine’s rentosertib to Generate Biomedicines’ AI-designed antibody for severe asthma, 2026 is the year artificial intelligence in drug discovery faces its definitive clinical test.
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.